FRIDAY, July 16, 2021 — Pfizer Inc. announced on Friday that the U.S. Food and Drug Administration has granted priority review to its COVID-19 vaccine, positioning the vaccine for full approval by January. The Pfizer vaccine has been administered to more Americans than any other shot so far in the U.S. vaccination campaign. According to… Read More: FDA to Prioritize Full Approval for Pfizer COVID Vaccine »
Loading the player… The U.S. Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for youngsters ages 12 to 15 by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year. The announcement is set to… Read More: FDA expected to OK Pfizer vaccine for teens within week »
WEDNESDAY, April 28, 2021 — Only 13.5% of people will suffer systemic side effects after getting Pfizer’s coronavirus vaccine, a new study finds. These systemic symptoms include headache, fatigue and tenderness. Most side effects are mild and peak in the day after being vaccinated, and they only last for one to two days, according to… Read More: About 1 in 7 Who Get Pfizer Vaccine Will Have… »